Clarivate PLC (NYSE:CLVT) Given Consensus Rating of “Reduce” by Brokerages

Clarivate PLC (NYSE:CLVT) has earned a consensus recommendation of “Reduce” from the eight brokerages that are currently covering the company, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $3.2167.

Several equities analysts have weighed in on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research note on Friday, March 27th. Royal Bank Of Canada lowered their price target on Clarivate from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 25th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Barclays reduced their price objective on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a research note on Wednesday, February 25th. Finally, Citigroup lowered their target price on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating for the company in a research note on Wednesday, March 4th.

Institutional Trading of Clarivate

A number of large investors have recently made changes to their positions in the company. Personal CFO Solutions LLC acquired a new stake in Clarivate during the 1st quarter worth $30,000. FreeGulliver LLC bought a new position in Clarivate during the first quarter worth about $30,000. Principal Financial Group Inc. acquired a new position in Clarivate in the first quarter valued at about $32,000. M&T Bank Corp bought a new stake in shares of Clarivate in the fourth quarter worth about $34,000. Finally, Parallel Advisors LLC increased its holdings in shares of Clarivate by 94.2% in the first quarter. Parallel Advisors LLC now owns 13,786 shares of the company’s stock worth $35,000 after acquiring an additional 6,687 shares in the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Stock Performance

Shares of Clarivate stock opened at $2.40 on Wednesday. The firm has a fifty day moving average of $2.53 and a two-hundred day moving average of $2.76. The stock has a market capitalization of $1.53 billion, a price-to-earnings ratio of -11.40 and a beta of 1.36. Clarivate has a 52 week low of $1.66 and a 52 week high of $4.77. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84.

Clarivate (NYSE:CLVT) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The business had revenue of $585.50 million for the quarter, compared to analyst estimates of $569.50 million. During the same period last year, the company earned $0.14 EPS. The firm’s revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, equities research analysts predict that Clarivate will post 0.65 EPS for the current year.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.